Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
With so many global regulation changes, staying informed is a challenge. Join other regulatory professionals as you navigate the gray together.
Updated by a group of distinguished regulatory experts, this new edition is a must-have handbook for regulatory professionals at all levels.
In light of the COVID-19 pandemic, the RAC Board has elected to offer online testing with live online proctoring this summer.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.
The RAPS store will be under maintenance Saturday, 13 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 11 July 2012 | By Alexander Gaffney, RAC
The European Medicines Agency (EMA) on Wednesday, 11 June released additional documents expanding the extent of its cooperation with the Pharmaceutical Inspection Co-Operation Scheme (PIC/S), first announced in December 2010.
PIC/S-composed of PIC and the PIC Scheme, which operate in tandem-works to promote inspection quality and cooperation among member counties, which include most European countries and, as of 2011, the US Food and Drug Administration (FDA). As of 2012, EMA is not a member of the PIC/S, though it is a "recognized partner."
The original agreement between the two organizations called for cooperating to advance the field of Good Manufacturing and Distribution Practice (GDMP) in order to share resources and avoid any duplication of efforts. In particular, the agency said it was interested in the exchange of information, including GDMP guidance documents developed by PIC/S and all legislation related to GDMP.
EMA sought to expand the 2010 agreement in May 2012 with an addendum, stating the two groups should work more on formal, rather than informal, harmonization procedures. "The GMP Guide and related documents should be harmonized between PIC/S and the GMDP Inspectors Working Group (IWG)," the addendum says, "although they need not be identical."
"To reach this goal, there should be an effective and co-operative exchange of information, including drafts and proposals, between both parties on all on-going revisions of existing documents or on the adoption of new documents, and this without delay," explained EMA and PIC/S.
To do this, both organizations will appoint liaison officers to regularly communicate with the other organization about "proposals influencing harmonized documents."
The more formalized approach to the harmonization of guidance documents will include the exchange of proposed and approved concept papers, participation in drafting groups, the exchange of draft documents, the opportunity for public and industry consultation, the preparation of a final draft, approval of final documents and the maintenance of finalized documents.
Read more:
Addendum to EMA-PIC/S's 2010 Agreement (May 2010)
EMA-PIC/S's 2010 Agreement
EMA's Landing Page for PIC/S Documents
2012 Confidentiality Agreement Signed by PIC/S
Tags: PIC Convention, PIC Scheme, GDMP, PIC/S, PIC, Harmonisation, GDP, harmonization, Latest News, GMP
Regulatory Focus newsletters
All the biggest regulatory news and happenings.